Related Experiment Video

Updated: Jul 28, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Neonatal bacterial meningitis

R A Polin1, M C Harris

  • 1College of Physicians and Surgeons, Columbia University, New York, USA. rap32@columbia.edu

Seminars in Neonatology : SN
|August 3, 2001
PubMed

Insights

Neonatal meningitis poses significant risks for infant survivors, leading to lifelong neurological issues. New strategies targeting the disease

Area of Science:

  • Neonatal intensive care
  • Pediatric infectious diseases
  • Neuroscience and neurology

Background:

  • Neonatal meningitis continues to be a severe condition despite advances in infant intensive care.
  • Survivors face high risks of long-term neurological impairments, with morbidity rates unchanged over decades.
  • Current intensive care unit (ICU) technology and antibiotics offer limited improvements in patient outcomes.

Purpose of the Study:

  • To explore novel therapeutic avenues for neonatal meningitis by understanding its pathogenesis.
  • To identify strategies that can mitigate brain injury associated with meningitis in neonates.
  • To develop interventions that interrupt bacterial entry into the central nervous system (CNS) and subsequent inflammation.

Main Methods:

  • Review of recent advancements in understanding meningitis pathogenesis.
  • Analysis of the pathophysiology of brain injury in neonatal meningitis.
  • Evaluation of potential strategies for modulating the inflammatory response.

Main Results:

  • Understanding disease mechanisms offers potential for new interventions.
  • Targeting bacterial entry and inflammatory pathways may improve outcomes.
  • Careful selection of anti-inflammatory strategies is crucial to preserve host defenses.

Conclusions:

  • Future improvements in neonatal meningitis outcomes likely depend on understanding pathogenesis and brain injury.
  • Interventions should focus on interrupting bacterial CNS invasion and modulating inflammation.
  • Therapeutic strategies must balance anti-inflammatory effects with the need to maintain essential host responses for recovery.

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Real-Time Quantification of Reactive Oxygen Species in Neutrophils Infected with Meningitic Escherichia Coli11:00

Real-Time Quantification of Reactive Oxygen Species in Neutrophils Infected with Meningitic Escherichia Coli

Published on: April 20, 2021

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...